Patent · US Active

Methods for producing antibody compositions with increased ADCC

US7708992B2 · kind B2 · utility

34Cited by
48References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 11, 2005
Grant dateMay 4, 2010
Priority date
Expiry dateDec 23, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to methods for modulating the antibody-dependent cellular cytotoxicity of an IgG antibody composition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.